Sentences with phrase «aortic heart»

The inherited conditions of aortic stenosis (a narrowing above the aortic heart valve or the aortic valve itself), atopy / allergic dermatitis (skin allergies), gastric dilatation volvulus (bloat / stomach dilation), early onset cataracts (a clouding of the lens inside the eye), dilated cardiomyopathy (enlargement of the chambers of the heart and thinning of the muscle wall), elbow dysplasia (abnormal growth of tissues that leads to malformation and degeneration of the joint), epilepsy (brain seizures), hypothyroidism (underactive production of thyroid hormones), intervertebral disk disease (problems with the disks between the vertebrae of the spine leading to neurological problems), and hepatic portosystemic shunt (an abnormal blood circulation where blood is diverted around the liver rather than into it) are more prevalent in purebred dogs than in mixed - breed.

The more frequently a hospital performs a minimally invasive technique called transcatheter aortic valve replacement, or TAVR, to replace a damaged aortic heart valve, the better patients fare, on average, immediately after the procedure, researchers reported at the American College of Cardiology's 65th Annual Scientific Session.

The company develops and markets a broad range of medical devices, such as advanced surgical technology, insulin pumps, transcatheter aortic heart valves, and much more.

Not exact matches

The company's shares fell as much as 8.1 percent in after - market trading as sales of its premium non-invasive device, used to replace diseased aortic valves without open - heart surgery, is its biggest growth driver.

If you could have found out that your baby had a critical aortic stenosis when it was an 18 - 20 week fetus, and had a fetal catheterization done to make sure that the left side of it's heart was able to grow, wouldn't you want that?

Former U.S. Secretary of State Henry Kissinger underwent heart surgery to replace an aortic valve at New York - Presbyterian Hospital.

The next stage is offering men over 65 a simple ultrasound test to detect early abdominal aortic aneurysm, or Triple A - the weakening of the main artery from heart to abdomen which kills over 3000 men a year — eventually saving more than 1600 lives each year.

Alcohol consumption was associated with a higher risk of stroke, heart failure, fatal aortic aneurysms, fatal hypertensive disease and heart failure and there were no clear thresholds where drinking less did not have a benefit.

Calcific aortic valve disease (CAVD)-- a disease that leaves the aortic valve stiff and calcified, preventing blood flow from the heart into the aorta — affects one quarter of the U.S. population aged 65 and over.

Transcatheter aortic valve replacement (TAVR) is used to replace a critically narrowed aortic valve, the valve between the heart and the main artery in the body.

They reviewed CT scans to assess how much abdominal fat had accumulated, its location and it's density in 1,106 participants from the Framingham Heart Study who received this imaging as part of a larger study to measure coronary and abdominal aortic calcification.

Aortic stenosis is a common disease, particularly among people 75 and older, in which one of the valves of the heart narrows and impedes blood flow to the body.

The most common symptoms of aortic stenosis are related to the fact that the heart has to work much harder to pump blood out.

The database is designed to provide information that can help hospitals improve the quality of care for patients with severe aortic stenosis and help patients make informed decisions about this new form of heart valve replacement.

UCLA scientists have found that conscious sedation — a type of anesthesia in which patients remain awake but are sleepy and pain - free — is a safe and viable option to general anesthesia for people undergoing a minimally invasive heart procedure called transcatheter aortic valve replacement.

In recent years, the use of transcatheter aortic valve replacement, or TAVR, has made the repair safer: Physicians place a new valve in the heart via a catheter inserted through the patient's leg, which results in less injury and an easier recovery than open heart surgery.

TAVR was first approved by the U.S. Food and Drug Administration (FDA) in 2011 to treat patients with severe aortic valve stenosis — a problem that occurs when the valve in the heart's main artery doesn't open fully and forces the heart to work harder to pump blood — for whom standard surgical valve replacement is too risky.

TR can be secondary to disorders of left - sided heart valves (mitral or aortic).

The mitral valve between the two left chambers of the heart has two leaflets, or cusps; the tricuspid, pulmonary and aortic valves each have three.

Acute aortic dissection (AAD) is a life - threatening condition in which blood leaks from the aorta, the major artery that carries blood from the heart to the body.

Hospital admissions for acute aortic dissection were highest during peak flu season November - March, according to research presented at the American Heart Association's Scientific Sessions 2014.

«Aortic valve stenosis, even though it involves only a little piece of tissue, has a catastrophic effect on the heart,» said W. David Merryman, associate professor of biomedical engineering.

«Aortic dissection in the chest is a life - threatening condition that requires immediate care, usually emergency surgery,» says Matias Hannuksela, medical doctor at the University Hospital of Umeå Heart Centre and author of the doctoral dissertation.

The FDA approved the CoreValve System to treat patients with severe aortic stenosis who are at high risk for surgery based on groundbreaking research showing the transcatheter heart valve had superior survival rates at one year when compared to open - heart surgery, the current gold standard for aortic valve replacement.

With this latest approval, the Orlando Health Heart Institute now also offers the CoreValve System to patients who are considered at high risk for a surgical heart procedure, serving a broader range of U.S. patients than any other transcatheter aortic vHeart Institute now also offers the CoreValve System to patients who are considered at high risk for a surgical heart procedure, serving a broader range of U.S. patients than any other transcatheter aortic vheart procedure, serving a broader range of U.S. patients than any other transcatheter aortic valve.

A minimally invasive procedure used to replace heart valves without open heart surgery appears to provide a durable remedy for people with a life - threatening form of heart disease in which the aortic valve opening narrows, diminishing blood flow.

Aortic stenosis is a common heart problem caused by a narrowing of the heart's aortic valve due to excessive calcium deposited on the valve leaAortic stenosis is a common heart problem caused by a narrowing of the heart's aortic valve due to excessive calcium deposited on the valve leaaortic valve due to excessive calcium deposited on the valve leaflets.

«The system means patients with aortic valve disease who are considered high risk for surgery, now have a new option,» said Deepak Vivek, MD, interventional cardiologist and director, Orlando Health Heart Institute Valve Center.

«Acute aortic dissections may be disguised as heart attacks, and we know that the genetic component of TAAD is strong — in about 20 % of patients, it is also found in family members.

Such cases involve not just cancer but conditions like aortic aneurysm, a deadly ballooning of the heart's major artery; Peyronie's disease, a deformity of the penis; and childhood cataracts.

Aortic dissection is a tear in the wall of the aorta (the large blood vessel that carries blood from the heart) to the body, causing the inner and middle layers of the aorta to separate (dissect).

Valve replacement is a treatment for aortic stenosis, which is narrowing of the valve between the main pumping chamber of the heart and the aorta, the main artery that carries blood from the heart to the rest of the body.

Worldwide, an estimated 300,000 people have severe aortic stenosis — a faulty valve in the main artery carrying blood out of the heart — and roughly a third of them are deemed unable to withstand the standard treatment of open - heart surgery to replace the valve.

TAVR, a procedure used to treat aortic valve stenosis, involves threading a long, thin, flexible tube, called a catheter, through the femoral artery in the leg to the heart.

Lederman explained that during TAVR, the surgeon places a catheter inside the heart and uses a balloon to open a new valve inside the aortic valve.

Aortic stenosis — a problem that occurs when the valve in the heart's main artery doesn't open fully — forces the heart to work harder to pump blood and is life - threatening over time.

Aortic valve stenosis is a fatal narrowing of the valve controlling blood leaving the heart to the rest of the body.

For Scherer's part, he believes, from his preliminary observations of one family, that a deletion of DNA on the 16th chromosome may result in autism accompanied by mental retardation as well as disruptions in the aortic valve (one of the heart's four valves) that may cause seizures.

The method, called Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA), will increase treatment options for high - risk patients who need heart valve procedures.

«Our results demonstrate that aortic arch pulse wave velocity is a highly significant independent predictor of subsequent white matter hyperintensity volume and provides a distinct contribution — along with systolic blood pressure, hypertension treatment, congestive heart failure and age — in predicting risk for cerebrovascular disease,» Dr. King said.

Dr. King and colleagues set out to evaluate the relationship between aortic arch pulse wave velocity and subsequent cerebral microvascular disease, independent of other cardiovascular risk factors, among 1,270 participants in the multiethnic Dallas Heart Study.

Collectively, our work has led to novel pathophysiologic and therapeutic insights for diseases, such as heart failure, aortic aneurysms, diabetes, and skeletal myopathies.

Their findings have tremendous implications for calcific aortic valve disease (CAVD), the third most common heart condition, and related forms of heart disease.

Wake Forest Baptist's cardiothoracic team and surgeons deliver exceptional results for all types of heart conditions through procedures such as aortic valve replacements, heart bypass surgery, heart transplants and surgeries and therapies for thoracic aneurysms.

The project focuses on defects in the development of the early heart, including hypoplastic left heart syndrome and bicuspid aortic valve disease.

Heart valve replacement is a common operation, but national practice guidelines do not distinguish between the aortic - valve and the mitral - valve.

Calcific aortic valve disease (CAVD) causes calcium to accumulate in heart valves and vessels until they harden like bone.

Among the 50 trials, 30 were primary prevention trials (general populations, smokers and workers exposed to asbestos, patients with oesophageal dysplasia, male physicians, patients with non-melanoma skin cancer, postmenopausal women, patients undergoing chronic haemodialysis, patients with end stage renal disease, ambulatory elderly women with vitamin D insufficiency, patients with chronic renal failure, older people with femoral neck fractures, patients with diabetes mellitus, elderly women with a low serum 25 - hydroxyvitamin D concentration, health professionals, people with a high fasting plasma total homocysteine concentration, or kidney transplant recipients), and 20 were secondary prevention trials (patients with cardiovascular disease, coronary heart disease, acute myocardial infarction, unstable angina, transient ischaemic attack, stroke, angiographically proved coronary atherosclerosis, vascular disease, or aortic valve stenosis).

Studies will focus on three main disease areas: arrhythmias; heart failure; and aortic, vascular or valve diseases.

Points to novel pathway for drug discovery, will be incorporated into tests to improve screening and early detection of abdominal aortic aneurysm, heart attack and PAD Reykjavik, ICELAND, 11 July 2010 — Scientists at deCODE genetics and academic colleagues from the...